TY  - BOOK
AU  - Tan Xiaoxia
TI  - Clinical observation of the transition from short-term intensive insulin therapy to IDegLira combined with metformin in Chinese patients with type 2 diabetes mellitus
KW  - IDegLira
KW  - metformin
KW  - short-term intensive insulin therapy
KW  - type 2 diabetes mellitus
N2  - The safety and efficacy of transitioning from short-term
intensive insulin therapy to a regimen of insulin degludec/liraglutide (IDegLira) combined with metformin in
type 2 diabetes mellitus patients is evaluated in the
present study. Conducted at Shenzhen Luohu Hospital
Group, the study involved 81 patients who switched
from continuous subcutaneous insulin infusion to
IDegLira and metformin after four days. Results showed
significant improvements: insulin doses decreased
from 40.28 to 14.79 IU, HbA1c levels fell from 9.94%
to 7.67%, and body weight slightly reduced. The transition also enhanced glycemic control, with reduced
mean glucose and variation, and increased time in
range
ER  -